 Positive results combined therapy surgery hyperthermic perfusion far-advanced gastric cancer clinical efficacy intraperitoneal hyperthermic perfusion IPHP far-advanced gastric cancer peritoneal seeding survival times patients distal subtotal gastrectomy total gastrectomy total gastrectomy concomitant resection intra-abdominal organs patients IPHP cancer cells present lavage Douglas pouch patients IPHP patients IPHP survival rate former group latter respect comparison survival time patients peritoneal seeding patients IPHP survival rate months whereas patients IPHP survival rates difference significant IPHP control groups peritoneal metastasis patients survival rates survival rates former latter generalized Wilcoxon test combined therapy promise extended survival patients far-advanced gastric cancer